T86.1 Z94.0
Conditions
Interventions
Group 1: Cohorte A: 500 NTX patients, retrospective analysis of serum at pre-NTX and post NTX months 1, 3, 6, 9, 12 and annually thereafter, other clinical data such as immunosuppression, graft functi
Sponsors
MUW
Eligibility
Sex/Gender
All
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: kidney transplantation
Exclusion criteria
Exclusion criteria: none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| association of TTV level and organ rejection | — |
Secondary
| Measure | Time frame |
|---|---|
| association of TTV level and clinical and immunological baseline characteristics, type and amount of immunosuppression, medical adherence, graft function [estimated glomerular filtration load (eGFR) and proteinuria], donor-specific antibodies (DSA) kinetic, infectious complications and cancer, death | — |
Countries
Austria
Contacts
Public ContactGregor Bond
MUW
Outcome results
None listed